Literature DB >> 26584734

Methylation of an intragenic alternative promoter regulates transcription of GARP.

Sonja Haupt1, Viktoria Sophie Apollonia Söntgerath1, Jan Leipe1, Hendrik Schulze-Koops1, Alla Skapenko1.   

Abstract

Alternative promoter usage has been proposed as a mechanism regulating transcriptional and translational diversity in highly elaborated systems like the immune system in humans. Here, we report that transcription of human glycoprotein A repetitions predominant (GARP) in regulatory CD4 T cells (Tregs) is tightly regulated by two alternative promoters. An intragenic promoter contains several CpGs and acts as a weak promoter that is demethylated and initiates transcription Treg-specifically. The strong up-stream promoter containing a CpG-island is, in contrast, fully demethylated throughout tissues. Transcriptional activity of the strong promoter was surprisingly down-regulated upon demethylation of the weak promoter. This demethylation-induced transcriptional attenuation regulated the magnitude of GARP expression and correlated with disease activity in rheumatoid arthritis. Treg-specific GARP transcription was initiated by synergistic interaction of forkhead box protein 3 (Foxp3) with nuclear factor of activated T cells (NFAT) and was underpinned by permissive chromatin remodeling caused by release of the H3K4 demethylase, PLU-1. Our findings describe a novel function of alternative promoters in regulating the extent of transcription. Moreover, since GARP functions as a transporter of transforming growth factor β (TGFβ), a cytokine with broad pleiotropic traits, GARP transcriptional attenuation by alternative promoters might provide a mechanism regulating peripheral TGFβ to avoid unwanted harmful effects.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative promoter; DNA methylation; GARP; Gene transcription; Transcriptional interference; Treg

Mesh:

Substances:

Year:  2015        PMID: 26584734     DOI: 10.1016/j.bbagrm.2015.11.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Multiple correlation analyses revealed complex relationship between DNA methylation and mRNA expression in human peripheral blood mononuclear cells.

Authors:  Fang-Fei Xie; Fei-Yan Deng; Long-Fei Wu; Xing-Bo Mo; Hong Zhu; Jian Wu; Yu-Fan Guo; Ke-Qin Zeng; Ming-Jun Wang; Xiao-Wei Zhu; Wei Xia; Lan Wang; Pei He; Peng-Fei Bing; Xin Lu; Yong-Hong Zhang; Shu-Feng Lei
Journal:  Funct Integr Genomics       Date:  2017-07-22       Impact factor: 3.410

2.  Altered Chromatin States Drive Cryptic Transcription in Aging Mammalian Stem Cells.

Authors:  Brenna S McCauley; Luyang Sun; Ruofan Yu; Minjung Lee; Haiying Liu; Dena S Leeman; Yun Huang; Ashley E Webb; Weiwei Dang
Journal:  Nat Aging       Date:  2021-08-02

3.  B lymphocytes confer immune tolerance via cell surface GARP-TGF-β complex.

Authors:  Caroline H Wallace; Bill X Wu; Mohammad Salem; Ephraim A Ansa-Addo; Alessandra Metelli; Shaoli Sun; Gary Gilkeson; Mark J Shlomchik; Bei Liu; Zihai Li
Journal:  JCI Insight       Date:  2018-04-05

Review 4.  [Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark].

Authors:  T Häupl; A Skapenko; B Hoppe; K Skriner; H Burkhardt; D Poddubnyy; S Ohrndorf; P Sewerin; U Mansmann; B Stuhlmüller; H Schulze-Koops; G-R Burmester
Journal:  Z Rheumatol       Date:  2018-05       Impact factor: 1.372

5.  Loosening chromatin and dysregulated transcription: a perspective on cryptic transcription during mammalian aging.

Authors:  Brenna S McCauley; Weiwei Dang
Journal:  Brief Funct Genomics       Date:  2022-01-25       Impact factor: 4.840

6.  Revealing the alternative promoter usage of SAF/MAZ gene by bichromatic fluorescent reporter construct.

Authors:  Jianbo Ren; Dawei Guo; Xiaoyi Wang; Chao Zhang; Bo Wang; Zhe Gao
Journal:  Biosci Rep       Date:  2019-01-18       Impact factor: 3.840

Review 7.  GARP as a Therapeutic Target for the Modulation of Regulatory T Cells in Cancer and Autoimmunity.

Authors:  Niklas Zimmer; Emily R Trzeciak; Barbara Graefen; Kazuki Satoh; Andrea Tuettenberg
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

8.  Mesenchymal stem cells inhibit T cell activation by releasing TGF-β1 from TGF-β1/GARP complex.

Authors:  Jian Niu; Wang Yue; Zhu Le-Le; Liu Bin; Xin Hu
Journal:  Oncotarget       Date:  2017-10-06

Review 9.  Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer.

Authors:  Alessandra Metelli; Mohammad Salem; Caroline H Wallace; Bill X Wu; Anqi Li; Xue Li; Zihai Li
Journal:  J Hematol Oncol       Date:  2018-02-20       Impact factor: 17.388

10.  Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32.

Authors:  Peter Lehmkuhl; Magdalena Gentz; Andres Caballero Garcia de Otezya; Bodo Grimbacher; Hendrik Schulze-Koops; Alla Skapenko
Journal:  Cell Mol Immunol       Date:  2021-05-31       Impact factor: 11.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.